WEDNESDAY, Sept. 6, 2017 -- A "biologic" drug in development to treat severe asthma reduces the rate of serious attacks by about two-thirds compared to a placebo drug, according to preliminary research findings.
If approved, the drug, tezepelumab, could join a group of costly medications that appear to offer relief when nothing else curbs respiratory distress.
WEDNESDAY, Aug. 23, 2017 -- Doctors sometimes prescribe a steroid for patients with bronchitis or other troublesome chest infections, but a new British study says the approach isn't warranted.
"Our study does not support the continued use of steroids as they do not have a clinically useful effect on symptom duration or severity," said study lead researcher Dr. Alastair Hay, who teaches primary care medicine at the University of Bristol.
WEDNESDAY, Aug. 16, 2017 -- Two major chronic lung diseases -- asthma and COPD -- kill nearly 4 million people worldwide annually, a new report finds.
The study calculates that 3.2 million people died in 2015 from COPD (chronic obstructive pulmonary disease) -- a group of lung conditions that includes emphysema and chronic bronchitis, often tied to smoking. Asthma caused another 400,000 deaths, the report found.